Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00128375 · ClinicalTrials.gov registry record · NA
Financial Incentives for Smoking Cessation
A NA study of Tobacco Use Disorder, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 878
- Enrollment target
- 1
- Study location
NCT00128375: Completed NA study of Tobacco Use Disorder, sponsored by University of Pennsylvania.
NCT00128375 is a NA study of Tobacco Use Disorder that has completed, run by University of Pennsylvania. The registered enrollment target is 878 participants, above the 227-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (287% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00128375, a NA study of Tobacco Use Disorder, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 878 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test the effectiveness of financial incentives for increasing long-term smoking cessation rates among employees at General Electric worksites throughout the United States.
Conditions Studied
Interventions
- BEHAVIORAL Financial incentives
Study Locations (1)
Pennsylvania
- University of Pennsylvania School of Medicine - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 878 participants |
| Start Date | 2005-03 |
| Est. Completion | 2008-04 |
| Phase | NA |
What the finished NCT00128375 record still lists
NCT00128375 is an interventional study that assigns participants to a tested intervention. The registered 878 participants enrollment target is mid-sized for trials with a published cap, above the 227-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (287% higher).
The record links to 1 condition, with Tobacco Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Financial incentives is the first listed.
NCT00128375 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00128375 about?
NCT00128375 is a clinical study titled "Financial Incentives for Smoking Cessation". The purpose of this study is to test the effectiveness of financial incentives for increasing long-term smoking cessation rates among employees at General Electric worksites throughout the United States.
What is the current status of trial NCT00128375?
This trial is currently completed. It is a NA study. The enrollment target is 878 participants. The study started on 2005-03. Estimated completion is 2008-04.
What conditions does trial NCT00128375 study?
This clinical trial studies the following conditions: Tobacco Use Disorder.
What interventions are being tested in trial NCT00128375?
The interventions under investigation include: Financial incentives (BEHAVIORAL).
Who is sponsoring clinical trial NCT00128375?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00128375 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00128375's enrollment target sits among peer trials
878 4th of 70 higher than 67 of 70 other Tobacco Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Smoking Cessation CM for Veterans With or at Risk for Cancer
RECRUITING · NA
-
Smoking Cessation Behavioral Treatment Study
RECRUITING · NA
-
Contingency Management for Veteran Smokers Undergoing Major Elective Surgery
RECRUITING · NA
-
A Future Thinking Intervention for Comorbid Tobacco Use Disorder and Bipolar Disorder
RECRUITING · NA
-
Young Adult Tobacco/Nicotine and Cannabis Co-use
RECRUITING · NA
-
Low Intensity Focused Ultrasound for Tobacco Use Disorder: High Resolution Targeting of the Human Insula
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06627647 · 878 participants · Phase 3
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-squamous NSCLC
- NCT07076199 · 877 participants · Phase 3
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
- NCT05174286 · 880 participants · NA
Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk
- NCT05454280 · 880 participants · Phase 3
Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia